To test the benefits of RJx-01 on muscle performance and molecular mechanisms relevant to sarcopenia, we employed multiple preclinical animal models, first Caenorhabditis elegans and subsequently 2 mouse models: an inducible muscle-specific optic atrophy 1–KO (OPA1-KO) mouse model and aged mice. This evidence concerns the gene OPA1 and sarcopenia.